Work

Temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukemia (ALL): A Children’s Oncology Group study.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.10029

Authors: Susan R. Rheingold, James Whitlock, Sarah K. Tasian, David T. Teachey, Michael J. Borowitz, Xiaowei Liu, Charlotte H. Ahern, Charles Minard, Elizabeth Fox, Brenda Weigel, Susan Blaney

Institutions: Children's Hospital of Philadelphia, Hospital for Sick Children, Johns Hopkins University, Children's Oncology Group, Baylor College of Medicine, University of Minnesota

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597754307

Cites:

Cited by: 2

Related to: 10